Elevated serum interleukin-41 levels as a potential biomarker in ankylosing spondylitis
Background Interleukin (IL)-41 is a novel cytokine, also known as Metrnl, and its role in ankylosing spondylitis (AS) remains unknown. The aim of this study is to measure the serum IL-41 levels in AS patients and their correlation with other clinical indicators.Methods This study recruited 106 parti...
Saved in:
| Main Authors: | Wubing Lu, Zhi Li, Shanjun Shi, Sicen Meng, Jieru Pang, Yan Li, Mingcai Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2025.2545732 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-09-01) -
Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01) -
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01) -
Ratios of neutrophils to lymphocytes and platelets to lymphocytes in ankylosing spondylitis with disease activity relationship
by: Shahla Taha Ahmad, et al.
Published: (2024-12-01) -
OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)